These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9384802)

  • 1. Correlation between MIB-1 staining indices and recurrence in low-grade astrocytomas.
    Hoshi M; Yoshida K; Shimazaki K; Sasaki H; Otani M; Kawase T
    Brain Tumor Pathol; 1997; 14(1):47-51. PubMed ID: 9384802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance.
    Kirkegaard LJ; DeRose PB; Yao B; Cohen C
    Am J Clin Pathol; 1998 Jan; 109(1):69-74. PubMed ID: 9426520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
    Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
    Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular proliferation in pilocytic and diffuse astrocytomas.
    Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
    J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis.
    Cummings TJ; Provenzale JM; Hunter SB; Friedman AH; Klintworth GK; Bigner SH; McLendon RE
    Acta Neuropathol; 2000 May; 99(5):563-70. PubMed ID: 10805102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
    Machen SK; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
    Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
    J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
    Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
    Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children.
    Czech T; Slavc I; Aichholzer M; Haberler C; Dietrich W; Dieckmann K; Koos W; Budka H
    J Neurooncol; 1999 Apr; 42(2):143-50. PubMed ID: 10421072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIB-1 staining index of pediatric meningiomas.
    Sandberg DI; Edgar MA; Resch L; Rutka JT; Becker LE; Souweidane MM
    Neurosurgery; 2001 Mar; 48(3):590-5; discussion 595-7. PubMed ID: 11270550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1 proliferation index predicts survival among patients with grade II astrocytoma.
    McKeever PE; Strawderman MS; Yamini B; Mikhail AA; Blaivas M
    J Neuropathol Exp Neurol; 1998 Oct; 57(10):931-6. PubMed ID: 9786243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
    Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
    Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors.
    Khalid H; Shibata S; Kishikawa M; Yasunaga A; Iseki M; Hiura T
    Cancer; 1997 Dec; 80(11):2133-40. PubMed ID: 9392336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
    Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
    Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
    Patt S; Giraldo M; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIB-1 labeling index in nonpilocytic astrocytoma of childhood: a study of 101 cases.
    Ho DM; Wong TT; Hsu CY; Ting LT; Chiang H
    Cancer; 1998 Jun; 82(12):2459-66. PubMed ID: 9635540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
    Prayson RA
    Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.